Hongmei Hu

机构：Jinggangshan University, Shanghai Innovative Research Center of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine · ORCID：0000-0001-7064-4037

发表论文 135 篇 · 总被引 1609 次 · h-index 22

代表论文

• Acevaltrate as a novel ferroptosis inducer with dual targets of PCBP1/2 and GPX4 in colorectal cancer (2025 · Signal Transduction and Targeted Therapy · 被引 41)
• Demethylzeylasteral induces PD-L1 ubiquitin–proteasome degradation and promotes antitumor immunity via targeting USP22 (2024 · Acta Pharmaceutica Sinica B · 被引 33)
• Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual‐Targeting BMI1 for Senescence Induction and CSN5 for PD‐L1 Degradation (2024 · Advanced Science · 被引 22)
• Network Medicine‐Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD‐L1 Expression via Targeting SPOP in Cancer (2024 · Advanced Science · 被引 19)
• Marine Natural Product Chagosendine C Induces Cuproptosis in Colorectal Cancer Cells by Targeting FDX1 (2025 · Journal of the American Chemical Society · 被引 17)
• Association Between Cognitive Frailty and Depression: A Prospective Cohort Study of Adults Aged 45 Years and Older in China (2024 · Clinical Interventions in Aging · 被引 11)